Australian biomarkers could lead to Alzheimer's blood test; BRAF mutation tags drug-sensitive melanoma;

> A panel of biomarkers from Australian research could lead to a blood test for Alzheimer's disease. Article | Article

> BRAF mutation tags melanomas sensitive to MEK inhibitor drugs. Press release | Abstract

> DiaGenic has reported 82% accuracy for its ADtect biomarker blood test for diagnosis of Alzheimer's disease. Press release

> DNA promoter methylation has potential as a diagnostic and therapeutic biomarker in gallbladder cancer. Abstract

> Knee injuries are linked with cartilage health biomarkers Article

> Population-based study picks out a risk-stratification biomarker panel for Barrett's esophagus, which may lead to cancer. Abstract

And Finally… IntegraGen has scored $2.4 million in funding to support development of its biomarker-based diagnostics. Article | Press release

Suggested Articles

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.

The FDA launched a center of excellence to oversee digital health products such as smartphone apps, wearable devices and software-based treatments.